AB 2664 Supports Innovation, Entrepreneurship at UC
A $22 million investment via California State Assembly Bill 2664 is supporting innovation and entrepreneurship at UC San Francisco and across the University of California system.
University of California San Francisco
Give to UCSFA $22 million investment via California State Assembly Bill 2664 is supporting innovation and entrepreneurship at UC San Francisco and across the University of California system.
Steven Altschuler and Lani Wu are using artificial intelligence to spot and label potential medical uses for biological compounds.
UCSF researchers have discovered a way to switch off the widely used CRISPR-Cas9 gene-editing system using newly identified anti-CRISPR proteins that are produced by bacterial viruses.
The National Science Foundation has awarded $24 million over five years for a new ‘blue-sky’ bioengineering center based at UCSF.
Ten years after the QB3 Garage incubator launched, the idea has grown an innovation ecosystem and become the catalyst for state legislation that could help turn ideas at UC campuses into job-providing companies.
UCSF announced the establishment of the Quantitative Biosciences Institute (QBI), to drive forward the application of computation, mathematics, and statistics toward a deeper understanding of complex problems in biology.
UCSF is partnering with the Salesforce Foundation to support Dreamforce 2015, where experts will explore ways to improve healthcare and research.
The inaugural Byers Family Distinguished Professorship has been awarded to Regis Kelly, PhD, in recognition of his visionary leadership at QB3, a thriving center of early-stage entrepreneurship and innovation that has capitalized on the premier health sciences research coming out of UCSF.
A record-breaking turnout—with more than 550 registered—packed Byers Auditorium and spilled into an overflow room at UCSF Mission Bay on Wednesday, June 4 for the launch of the Rosenman Institute.
San Francisco Mayor Ed Lee celebrated the recent launch of the California Institute for Quantitative Biosciences' (QB3) new bioscience incubator, near the ever-growing UC San Francisco campus at Mission Bay.
UCSF's “Idea to IPO” course is not a typical course. Instead, it’s an opportunity for students to bring their dreams and learn how to turn them into reality.
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.